The authors performed paired single-cell RNA and T-cell receptor sequencing of cells from site-matched tumors of patients with basal cell carcinoma or squamous cell carcinoma before and after anti-PD-1 therapy. Here, PDCD1 is linked to basal cell carcinoma.